Literature DB >> 1971768

Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on biological aspects of mental illness.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1971768

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  14 in total

Review 1.  Managing antipsychotic-induced parkinsonism.

Authors:  D C Mamo; R A Sweet; M S Keshavan
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

2.  The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine.

Authors:  Pål Gjerden; Lars Slørdal; Jørgen G Bramness
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

3.  Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up.

Authors:  Pål Gjerden; Lars Slørdal; Jørgen G Bramness
Journal:  Eur J Clin Pharmacol       Date:  2010-06-03       Impact factor: 2.953

Review 4.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 5.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

6.  Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia.

Authors:  Julie Eve Desmarais; Linda Beauclair; Lawrence Annable; Marie-Claire Bélanger; Theodore T Kolivakis; Howard C Margolese
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

Review 7.  The problems of anticholinergic adverse effects in older patients.

Authors:  M Feinberg
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

8.  Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents.

Authors:  Pål Gjerden; Lars Slørdal; Jørgen G Bramness
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

9.  The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999.

Authors:  Gabor S Ungvari; Yiu Gar Chung; Yip Ka Chee; Ng Fung-Shing; Tang Wai Kwong; Helen F K Chiu
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

10.  Managing antipsychotic-induced acute and tardive dystonia.

Authors:  M Raja
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.